{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:17:14Z","timestamp":1789345034583,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T00:00:00Z","timestamp":1542412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-PHUC-001"],"award-info":[{"award-number":["ANR-11-PHUC-001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00277-018-3549-5","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T21:52:08Z","timestamp":1542405128000},"page":"615-623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The impact of chronic myeloid leukemia on employment: the French prospective study"],"prefix":"10.1007","volume":"98","author":[{"given":"Sandra","family":"De Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Vayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Despas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Strumia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Podevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Delabesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Soulat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Herin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,17]]},"reference":[{"key":"3549_CR1","unstructured":"Estimation nationale de l\u2019incidence des cancers en France entre 1980 et 2012 (2013) Maladies chroniques et traumatismes\/Rapports et synth\u00e8ses\/Publications et outils\/Accueil [Internet]. Disponible sur: \n                    http:\/\/invs.santepubliquefrance.fr\/Publications-et-outils\/Rapports-et-syntheses\/Maladies-chroniques-et-traumatismes\/2013\/Estimation-nationale-de-l-incidence-des-cancers-en-France-entre-1980-et-2012\n                    \n                  . Accessed 24 Nov 2017"},{"key":"3549_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12935-017-0460-4","volume":"17","author":"L Repsold","year":"2017","unstructured":"Repsold L, Pool R, Karodia M, Tintinger G, Joubert AM (2017) An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia. Cancer Cell Int 17:89 Disponible sur: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5664592\/","journal-title":"Cancer Cell Int"},{"key":"3549_CR3","unstructured":"Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional... - Abstract - Europe PMC [Internet]. Disponible sur: \n                    http:\/\/europepmc.org\/abstract\/med\/27260015\n                    \n                  . Accessed 24 Nov 2017"},{"issue":"8","key":"3549_CR4","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1080\/03007995.2016.1185399","volume":"32","author":"M Breccia","year":"2016","unstructured":"Breccia M, Efficace F (2016) Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: do we know enough? Current Med Res Opin 32(8):1453\u20131454","journal-title":"Current Med Res Opin"},{"issue":"4","key":"3549_CR5","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00520-012-1630-5","volume":"21","author":"KM Phillips","year":"2013","unstructured":"Phillips KM, Pinilla-Ibarz J, Sotomayor E, Lee MR, Jim HSL, Small BJ, Sokol L, Lancet J, Tinsley S, Sweet K, Komrokji R, Jacobsen PB (2013) Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison. Support Care Cancer 21(4):1097\u20131103","journal-title":"Support Care Cancer"},{"issue":"4","key":"3549_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s11764-013-0300-z","volume":"7","author":"TA Horsboel","year":"2013","unstructured":"Horsboel TA, Nielsen CV, Nielsen B, Jensen C, Andersen NT, de Thurah A (2013) Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study. J Cancer Surviv 7(4):614\u2013623","journal-title":"J Cancer Surviv"},{"issue":"8","key":"3549_CR7","first-page":"2113","volume":"22","author":"N Hamerschlak","year":"2014","unstructured":"Hamerschlak N, de Souza C, Cornacchioni AL, Pasquini R, Tabak D, Spector N, Steagall M (2014) Quality of life of chronic myeloid leukemia patients in Brazil: ability to work as a key factor. Support Care Cancer 22(8):2113\u20132118","journal-title":"Support Care Cancer"},{"issue":"5","key":"3549_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3109\/0284186X.2014.999871","volume":"54","author":"TA Horsboel","year":"2015","unstructured":"Horsboel TA, Nielsen CV, Nielsen B, Andersen NT, De Thurah A (2015) Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies. Acta Oncol 54(5):743\u2013749","journal-title":"Acta Oncol"},{"issue":"6","key":"3549_CR9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Martinelli G, Mayer J, Muller MC, Niederwieser D, Pane F, Radich JP, Rousselot P, Saglio G, Saussele S, Schiffer C, Silver R, Simonsson B, Steegmann JL, Goldman JM, Hehlmann R (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 122(6):872\u2013884","journal-title":"Blood"},{"key":"3549_CR10","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE)|Common Terminology Criteria for Adverse Events (CTCAE)|Protocol Development|CTEP [Internet]. Available from: \n                    https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50\n                    \n                  . Accessed 14 Jun 2018"},{"issue":"4","key":"3549_CR11","first-page":"391","volume":"43","author":"SL Chow","year":"2014","unstructured":"Chow SL, Ting AS, Su TT (2014) Development of conceptual framework to understand factors associated with return to work among cancer survivors: a systematic review. Iran J Public Health 43(4):391\u2013405","journal-title":"Iran J Public Health"},{"issue":"7","key":"3549_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/216507990705500705","volume":"55","author":"NM Nachreiner","year":"2007","unstructured":"Nachreiner NM, Dagher RK, McGovern PM, Baker BA, Alexander BH, Gerberich SG (2007) Successful return to work for cancer survivors. AAOHN J 55(7):290\u2013295","journal-title":"AAOHN J"},{"issue":"26","key":"3549_CR13","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","volume":"118","author":"A Fabarius","year":"2011","unstructured":"Fabarius A, Leitner A, Hochhaus A, M\u00fcller MC, Hanfstein B, Haferlach C et al (2011) Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML study IV. Blood 118(26):6760\u20136768","journal-title":"Blood"},{"issue":"2","key":"3549_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00277-015-2541-6","volume":"95","author":"F Efficace","year":"2016","unstructured":"Efficace F, Rosti G, Breccia M, Cottone F, Giesinger JM, Stagno F, Iurlo A, Russo Rossi A, Luciano L, Martino B, Galimberti S, Turri D, Bergamaschi M, Tiribelli M, Fava C, Angelucci E, Mandelli F, Baccarani M (2016) The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia. Ann Hematol 95(2):211\u2013219","journal-title":"Ann Hematol"},{"issue":"2","key":"3549_CR15","first-page":"165","volume":"38","author":"R Unnikrishnan","year":"2017","unstructured":"Unnikrishnan R, Veeraiah S, Ganesan P (2017) Symptom burden and quality of life issues among patients of chronic myeloid leukemia on long-term imatinib therapy. Indian J Med Paediatr Oncol 38(2):165\u2013168","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"2","key":"3549_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11899-016-0306-5","volume":"11","author":"KE Flynn","year":"2016","unstructured":"Flynn KE, Atallah E (2016) Quality of life and long-term therapy in patients with chronic myeloid leukemia. Curr Hematol Malig Rep 11(2):80\u201385","journal-title":"Curr Hematol Malig Rep"},{"key":"3549_CR17","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2147\/PPA.S92125","volume":"9","author":"M Kek\u00e4le","year":"2015","unstructured":"Kek\u00e4le M, Peltoniemi M, Airaksinen M (2015) Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment. Patient Prefer Adherence 9:1733\u20131740","journal-title":"Patient Prefer Adherence"},{"issue":"11","key":"3549_CR18","first-page":"808","volume":"31","author":"CB Saiki","year":"2017","unstructured":"Saiki CB, Waldfogel JM, Lee EK, Smith TJ (2017) Strategies for addressing cancer patients\u2019 complaints of fatigue. Oncology (Williston Park, NY) 31(11):808\u2013812","journal-title":"Oncology (Williston Park, NY)"},{"issue":"7","key":"3549_CR19","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/leu.2013.51","volume":"27","author":"F Efficace","year":"2013","unstructured":"Efficace F, Baccarani M, Breccia M, Cottone F, Alimena G, Deliliers GL, Barat\u00e8 C, Specchia G, di Lorenzo R, Luciano L, Turri D, Martino B, Stagno F, Dabusti M, Bergamaschi M, Leoni P, Simula MP, Levato L, Fava C, Veneri D, Sica S, Rambaldi A, Rosti G, Vignetti M, Mandelli F (2013) Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. Leukemia 27(7):1511\u20131519","journal-title":"Leukemia"},{"issue":"12","key":"3549_CR20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1159\/000485079","volume":"40","author":"U Seifart","year":"2017","unstructured":"Seifart U, Schmielau J (2017) Return to work of cancer survivors. Oncol Res Treat 40(12):760\u2013763","journal-title":"Oncol Res Treat"},{"issue":"12","key":"3549_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1159\/000485187","volume":"40","author":"J Schmielau","year":"2017","unstructured":"Schmielau J, Rick O, Reuss-Borst M, Kalusche-Bontemps E-M, Steimann M (2017) Rehabilitation of cancer survivors with long-term toxicities. Oncol Res Treat 40(12):764\u2013771","journal-title":"Oncol Res Treat"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3549-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T19:02:50Z","timestamp":1573930970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3549-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,17]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3549"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3549-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,17]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study that involved human participants were in accordance with the ethical standards of the institutional committee, national research committee, and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The datasets generated and analyzed during the study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}